SYNAPTIC RES LLC has a total of 27 patent applications. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are DELTAGEN PROTEOMICS INC, SHANGHAI CELL THERAPY GROUP CO LTD and STATENS BAKTERIOLOGISKA LAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | United States | 5 | |
#5 | Republic of Korea | 4 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Environmental technology | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Measuring microorganism processes | |
#4 | Medical preparations | |
#5 | Analysing materials | |
#6 | Climate change adaptation technologies | |
#7 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Oyler George A | 23 |
#2 | Tsai Yien Che | 11 |
#3 | Chang Yung-Nien | 7 |
#4 | Rosenberg Julian | 5 |
#5 | Oyler George | 4 |
#6 | Weeks Donald P | 3 |
#7 | Rosenberg Julian N | 3 |
#8 | Gertz Barry | 2 |
#9 | Chang Yung Nien | 2 |
#10 | Yung-Nien Chang | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021028868A1 | Cells highly sensitive to clostridial neurotoxin | |
WO2020245810A1 | Genetically engineered cells sensitive for clostridial neurotoxins | |
EP2694543A2 | Single chain antibodies for photosynthetic microorganisms and methods of use | |
KR20130111954A | N-end rule protease activity indication methods and uses thereof | |
WO2011071956A2 | Method for identification of protease activity inhibitors and assaying the presence of protease activity | |
WO2011053935A2 | Enhanced gene expression in algae | |
CN102612562A | A novel protein delivery system to generate induced pluripotent stem (ips) cells or tissue-specific cells | |
US2010015116A1 | Designer ubiquitin ligases having a non-cleavable SNAP25 domain and E3-ligase domain |